Oncotarget

January 8, 2019

View Archive »

About The Cover

The cover for issue 3 of Oncotarget features  images of a research autopsy to characterize clonal heterogeneity in a rare hypermutated cancer, by Chen, et al.

 

Table of Contents

Editorial

Multimodal treatments for advanced prostate cancer

Multimodal treatments for advanced prostate cancer

https://doi.org/10.18632/oncotarget.26525

Izak Faiena, Isaac Y. Kim,  and Thomas L. Jang
255-256
PDF  |  How to cite

Plasmacytomas: many faces of one disease, or many diseases with one face?

Plasmacytomas: many faces of one disease, or many diseases with one face?

https://doi.org/10.18632/oncotarget.26557

Gaurav Goyal,  and Wilson I. Gonsalves
257-258
PDF  |  How to cite

Research Perspectives

Gestational tumors as a model to probe reticulate evolution in human neoplasia

Gestational tumors as a model to probe reticulate evolution in human neoplasia

https://doi.org/10.18632/oncotarget.26510

Yuri Lazebnik
259-262
Abstract  |  PDF  |  Full Text  |  How to cite

Priority Research Papers

Cell cycle regulation of condensin Smc4

Cell cycle regulation of condensin Smc4

https://doi.org/10.18632/oncotarget.26467

Hsu Wei-Shan, Vas C. Amit,  and Duncan J. Clarke
263-276
Abstract  |  PDF  |  Full Text  |  How to cite

Research Papers

Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy

Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy

https://doi.org/10.18632/oncotarget.26352

Hui-Zi Chen, Russell Bonneville, Lianbo Yu, Michele R. Wing, Julie W. Reeser, Melanie A. Krook, Jharna Miya, Eric Samorodnitsky, Amy Smith, Dorrelyn Martin, Thuy Dao, Qishan Guo, David Liebner, Aharon G. Freud, Patricia Allenby,  and Sameek Roychowdhury
277-288
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Video Interview

Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies

Analysis of pituitary adenoma expression patterns suggests a potential role for the NeuroD1 transcription factor in neuroendocrine tumor-targeting therapies

https://doi.org/10.18632/oncotarget.26513

Lubov Borisovna Mitrofanova, Olga Mikhailovna Vorobeva,  and Andrey Nikolaevich Gorshkov
289-312
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Pairwise combinations of chemical compounds that delay yeast chronological aging through different signaling pathways display synergistic effects on the extent of aging delay

Pairwise combinations of chemical compounds that delay yeast chronological aging through different signaling pathways display synergistic effects on the extent of aging delay

https://doi.org/10.18632/oncotarget.26553

Pamela Dakik, Mélissa McAuley, Marisa Chancharoen, Darya Mitrofanova, Monica Enith Lozano Rodriguez, Jennifer Anne Baratang Junio, Vicky Lutchman, Berly Cortes, Éric Simard,  and Vladimir I. Titorenko
313-338
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Integrative system genetic analysis reveals mRNA-lncRNA network associated with mouse spontaneous lung cancer susceptibility

Integrative system genetic analysis reveals mRNA-lncRNA network associated with mouse spontaneous lung cancer susceptibility

https://doi.org/10.18632/oncotarget.26554

Yu Zhou,  and Ming You
339-351

Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy

Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy

https://doi.org/10.18632/oncotarget.26564

Tomoki Yamano, Shuji Kubo, Aya Yano, Tomoko Kominato, Shino Tanaka, Masataka Ikeda,  and Naohiro Tomita
352-367
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)

https://doi.org/10.18632/oncotarget.26569

Sylvia Moeckel, Kelly LaFrance, Julia Wetsch, Corinna Seliger, Markus J. Riemenschneider, Martin Proescholdt, Peter Hau,  and Arabel Vollmann-Zwerenz
368-382
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.26555

Devis Pascut, Caecilia Hapsari Ceriapuri Sukowati, Giulia Antoniali, Giovanna Mangiapane, Silvia Burra, Luca Giovanni Mascaretti, Matteo Rossano Buonocore, Lory Saveria Crocè, Claudio Tiribelli,  and Gianluca Tell
383-394
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)

https://doi.org/10.18632/oncotarget.26571

Marta Łukaszewicz-Zając, Mariusz Gryko, Sara Pączek, Maciej Szmitkowski, Bogusław Kędra,  and Barbara Mroczko
395-403
Abstract  |  PDF  |  Full Text  |  How to cite

Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity

Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity

https://doi.org/10.18632/oncotarget.26552

Masahiro Ogawa, Tatsuki Yaginuma, Chihiro Nakatomi, Tsuyoshi Nakajima, Yukiyo Tada-Shigeyama, William N. Addison, Mariko Urata, Takuma Matsubara, Koji Watanabe, Kou Matsuo, Tsuyoshi Sato, Hiromi Honda, Hisako Hikiji, Seiji Watanabe,  and Shoichiro Kokabu
404-414
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC